NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Good Points Red,


At the risk of repeating myself, I want to reiterate what impressed me the most.

I've been waiting for someone to give me compassionate use statistics,

Last evening, we finally received them.


Not including the phase 3 trial on DCVAX-L, over 200 patients received over 1000 treatments with DCVAX-L over the past 10 years.


* The cancers included (but were not limited to) Brain, Esoghageal and Merkel cell carcinoma.
* More than 80% of those 200 patients responded to DCVAX-L.
* Progression Free Survival (PFS) was, on average, extended at least one-and-a-half years beyond standard of care.
* Overall Survival (OS) was, on average, extended at least one-and-a-half years beyond standard of care.
* Only one patient had a serious adverse event possibly related to DCVAX-L out of 200 very sick cancer patients over 10 years.


(Prior to last night, we received a much smaller sampling from approximately 37 total patients in 2-3 phase 1/2 trials. In other words, last night's presentation just added over 160 patients worth of information.)